Literature DB >> 7988653

Antitussive effect of dihydroetorphine in mice.

J Kamei1, Y Iwamoto, T Suzuki, M Misawa, H Nagase, Y Kasuya.   

Abstract

The present study examined the opioid receptors involved in the antitussive effect of dihydroetorphine in mice. Dihydroetorphine suppressed coughs dose dependently at doses between 0.1-1 micrograms/kg i.p. Blockade of mu-opioid receptors by pretreatment with beta-funaltrexamine significantly reduced the antitussive effect of dihydroetorphine. Furthermore, the antitussive effect of dihydroetorphine was also antagonized by nor-binaltorphimine, a kappa-opioid receptor antagonist. However, pretreatment with naltrindole, a delta-opioid receptor antagonist, did not affect the antitussive effect of dihydroetorphine. These results indicate that the antitussive effect of dihydroetorphine is mediated by the activation of mu-opioid receptors and of kappa-opioid receptors, but not delta-opioid receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7988653     DOI: 10.1016/0014-2999(94)90347-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Effects of second generation of histamine H1 antagonists, cetirizine and ebastine, on the antitussive and rewarding effects of dihydrocodeine in mice.

Authors:  Junzo Kamei; Kayo Morita; Shigeo Miyata; Kenji Onodera
Journal:  Psychopharmacology (Berl)       Date:  2003-01-21       Impact factor: 4.530

Review 2.  Central mechanisms II: pharmacology of brainstem pathways.

Authors:  D C Bolser
Journal:  Handb Exp Pharmacol       Date:  2009
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.